JP2022519696A - Tyk2偽キナーゼリガンド - Google Patents
Tyk2偽キナーゼリガンド Download PDFInfo
- Publication number
- JP2022519696A JP2022519696A JP2021546005A JP2021546005A JP2022519696A JP 2022519696 A JP2022519696 A JP 2022519696A JP 2021546005 A JP2021546005 A JP 2021546005A JP 2021546005 A JP2021546005 A JP 2021546005A JP 2022519696 A JP2022519696 A JP 2022519696A
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- acceptable salt
- solvate
- alkyl
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962802642P | 2019-02-07 | 2019-02-07 | |
| US62/802,642 | 2019-02-07 | ||
| PCT/US2020/017314 WO2020163778A1 (en) | 2019-02-07 | 2020-02-07 | Tyk2 pseudokinase ligands |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022519696A true JP2022519696A (ja) | 2022-03-24 |
| JP2022519696A5 JP2022519696A5 (cg-RX-API-DMAC7.html) | 2023-02-15 |
Family
ID=71947508
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021546005A Pending JP2022519696A (ja) | 2019-02-07 | 2020-02-07 | Tyk2偽キナーゼリガンド |
Country Status (12)
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2022553841A (ja) * | 2019-11-08 | 2022-12-26 | ベンティックス バイオサイエンシーズ,インク. | Tyk2偽キナーゼリガンド |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RS66346B1 (sr) | 2018-10-22 | 2025-01-31 | Alumis Inc | Inhibitori tyk2 i njihova upotreba |
| SG11202110523XA (en) | 2019-03-26 | 2021-10-28 | Ventyx Biosciences Inc | Tyk2 pseudokinase ligands |
| IL301385A (en) * | 2020-09-16 | 2023-05-01 | Alumis Inc | TYK2 inhibitors and their use |
| CN117043164A (zh) * | 2021-01-19 | 2023-11-10 | 安锐生物医药科技(广州)有限公司 | 咪唑并哒嗪或吡唑并嘧啶化合物和组合物 |
| KR20240111312A (ko) | 2021-10-25 | 2024-07-16 | 카이메라 쎄라퓨틱스 인코포레이티드 | Tyk2 분해제 및 이의 용도 |
| CN121941683A (zh) * | 2023-09-22 | 2026-04-28 | 杭州多域生物技术有限公司 | 含氮并环类化合物、其药物组合物及其应用 |
| WO2025165746A1 (en) * | 2024-01-30 | 2025-08-07 | Ennovathera, Inc. | Certain chemical entities, compositions, and methods |
| WO2025168035A1 (zh) * | 2024-02-07 | 2025-08-14 | 合肥羿科医药有限公司 | 杂环类化合物、其药物组合物及其应用 |
| CN118084920A (zh) * | 2024-02-26 | 2024-05-28 | 镇江圣安医药有限公司 | 五元杂芳环并嘧啶-3-甲酰胺衍生物及其组合物和用途 |
| WO2025214467A1 (zh) * | 2024-04-12 | 2025-10-16 | 江苏恒瑞医药股份有限公司 | 氨基取代的杂芳环类化合物、其制备方法及其在医药上的应用 |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006519226A (ja) * | 2003-02-28 | 2006-08-24 | 帝人ファーマ株式会社 | ピラゾロ[1,5−a]ピリミジン誘導体 |
| JP2012507569A (ja) * | 2008-10-31 | 2012-03-29 | ジェネンテック, インコーポレイテッド | ピラゾロピリミジンjak阻害剤化合物と方法 |
| JP2019501125A (ja) * | 2015-11-18 | 2019-01-17 | ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company | IL−12、IL−23および/またはIFNα応答のモジュレーターとして有用なイミダゾピリダジン化合物 |
| WO2019023468A1 (en) * | 2017-07-28 | 2019-01-31 | Nimbus Lakshmi, Inc. | TYK2 INHIBITORS AND USES THEREOF |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW201720828A (zh) * | 2015-11-23 | 2017-06-16 | 赫孚孟拉羅股份公司 | 治療性化合物及組合物以及其使用方法 |
| AU2018230737B2 (en) * | 2017-03-08 | 2022-09-22 | Takeda Pharmaceutical Company Limited | Tyk2 inhibitors, uses, and methods for production thereof |
| WO2018215390A1 (en) * | 2017-05-22 | 2018-11-29 | F. Hoffmann-La Roche Ag | Therapeutic compounds and compositions, and methods of use thereof |
| EP3849981B1 (en) * | 2018-09-10 | 2023-02-01 | Eli Lilly and Company | Pyrazolo[1,5-a]pyrimidine-3-carboxamide derivatives useful in the treatment of psoriasis and systemic lupus erythematosus |
| JP7619951B2 (ja) * | 2018-10-15 | 2025-01-22 | 武田薬品工業株式会社 | Tyk2阻害剤およびその使用 |
| TWI800696B (zh) * | 2018-12-10 | 2023-05-01 | 美商美國禮來大藥廠 | 7-(甲基胺基)吡唑并[1,5-a]嘧啶-3-甲醯胺衍生物 |
| CN114929226B (zh) * | 2019-11-08 | 2024-09-27 | 温缇克斯生物科学公司 | Tyk2假激酶配体 |
-
2020
- 2020-02-07 SG SG11202108619SA patent/SG11202108619SA/en unknown
- 2020-02-07 CN CN202080026979.3A patent/CN113677347A/zh active Pending
- 2020-02-07 AU AU2020218267A patent/AU2020218267A1/en not_active Abandoned
- 2020-02-07 EP EP20752194.9A patent/EP3920931A4/en not_active Withdrawn
- 2020-02-07 JP JP2021546005A patent/JP2022519696A/ja active Pending
- 2020-02-07 KR KR1020217028660A patent/KR20210124409A/ko not_active Ceased
- 2020-02-07 CA CA3129438A patent/CA3129438A1/en active Pending
- 2020-02-07 WO PCT/US2020/017314 patent/WO2020163778A1/en not_active Ceased
- 2020-02-07 US US17/428,953 patent/US20220135567A1/en not_active Abandoned
- 2020-02-07 BR BR112021015616A patent/BR112021015616A2/pt not_active Application Discontinuation
- 2020-02-07 MX MX2021009555A patent/MX2021009555A/es unknown
-
2021
- 2021-08-08 IL IL285429A patent/IL285429A/en unknown
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006519226A (ja) * | 2003-02-28 | 2006-08-24 | 帝人ファーマ株式会社 | ピラゾロ[1,5−a]ピリミジン誘導体 |
| JP2012507569A (ja) * | 2008-10-31 | 2012-03-29 | ジェネンテック, インコーポレイテッド | ピラゾロピリミジンjak阻害剤化合物と方法 |
| JP2019501125A (ja) * | 2015-11-18 | 2019-01-17 | ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company | IL−12、IL−23および/またはIFNα応答のモジュレーターとして有用なイミダゾピリダジン化合物 |
| WO2019023468A1 (en) * | 2017-07-28 | 2019-01-31 | Nimbus Lakshmi, Inc. | TYK2 INHIBITORS AND USES THEREOF |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2022553841A (ja) * | 2019-11-08 | 2022-12-26 | ベンティックス バイオサイエンシーズ,インク. | Tyk2偽キナーゼリガンド |
| JP7635228B2 (ja) | 2019-11-08 | 2025-02-25 | ベンティックス バイオサイエンシーズ,インク. | Tyk2偽キナーゼリガンド |
Also Published As
| Publication number | Publication date |
|---|---|
| US20220135567A1 (en) | 2022-05-05 |
| IL285429A (en) | 2021-09-30 |
| EP3920931A1 (en) | 2021-12-15 |
| MX2021009555A (es) | 2021-10-13 |
| EP3920931A4 (en) | 2022-08-10 |
| KR20210124409A (ko) | 2021-10-14 |
| BR112021015616A2 (pt) | 2021-11-09 |
| AU2020218267A1 (en) | 2021-09-30 |
| SG11202108619SA (en) | 2021-09-29 |
| CN113677347A (zh) | 2021-11-19 |
| WO2020163778A1 (en) | 2020-08-13 |
| CA3129438A1 (en) | 2020-08-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102938141B1 (ko) | Tyk2 슈도키나제 리간드 | |
| JP2022529311A (ja) | Tyk2偽キナーゼリガンド | |
| AU2020218267A1 (en) | TYK2 pseudokinase ligands | |
| JP7617030B2 (ja) | Jak阻害剤 | |
| JP2022549435A (ja) | Jak阻害剤 | |
| JP2022544174A (ja) | Jak阻害剤 | |
| CA3186635A1 (en) | Therapeutic agents targeting gpr35 | |
| HK40066192B (en) | Tyk2 pseudokinase ligands | |
| HK40066192A (zh) | Tyk2假激酶配体 | |
| HK40080028B (en) | Tyk2 pseudokinase ligands | |
| HK40064378A (en) | Tyk2 pseudokinase ligands | |
| HK40080028A (en) | Tyk2 pseudokinase ligands | |
| HK40080624A (en) | Jak inhibitors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210831 |
|
| RD12 | Notification of acceptance of power of sub attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7432 Effective date: 20221222 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20221222 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230206 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20230206 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20240125 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20240213 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20240422 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20240621 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240813 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20241204 |